Global Naphazoline Hydrochloride Market Research Report 2023

Publication ID:

PB503235621

Publication Date:

March 15, 2023

Pages:

108

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Naphazoline is a medicine used as a decongestant. It is a sympathomimetic agent with marked alpha adrenergic activity. It is a vasoconstrictor with a rapid action in reducing swelling when applied to mucous membrane. It acts on alpha-receptors in the arterioles of the conjunctiva to produce constriction, resulting in decreased congestion.
Highlights
The global Naphazoline Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Naphazoline Hydrochloride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Naphazoline Hydrochloride is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Naphazoline Hydrochloride include Novartis AG, Allergan, Inc., Meda Pharmaceuticals Inc, Bausch & Lomb Inc, Cigna, Similasan Corporation, Visine, Alcon and Viva Opti-Free, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Naphazoline Hydrochloride, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Naphazoline Hydrochloride.
The Naphazoline Hydrochloride market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Naphazoline Hydrochloride market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Naphazoline Hydrochloride manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Novartis AG
Allergan, Inc.
Meda Pharmaceuticals Inc
Bausch & Lomb Inc
Cigna
Similasan Corporation
Visine
Alcon
Viva Opti-Free
Bausch & Lomb
Systane
Rite Aid
Walgreens
Staples
Clear eyes
Refresh
Murine
Tears naturale
Genteal
Segment by Type
Eyestrain
Conjunctival hyperemia
Other
Segment by Application
Adult
Children
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Naphazoline Hydrochloride manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Naphazoline Hydrochloride in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Naphazoline Hydrochloride Market Overview
1.1 Product Overview and Scope of Naphazoline Hydrochloride
1.2 Naphazoline Hydrochloride Segment by Type
1.2.1 Global Naphazoline Hydrochloride Market Value Comparison by Type (2023-2029)
1.2.2 Eyestrain
1.2.3 Conjunctival hyperemia
1.2.4 Other
1.3 Naphazoline Hydrochloride Segment by Application
1.3.1 Global Naphazoline Hydrochloride Market Value by Application: (2023-2029)
1.3.2 Adult
1.3.3 Children
1.4 Global Naphazoline Hydrochloride Market Size Estimates and Forecasts
1.4.1 Global Naphazoline Hydrochloride Revenue 2018-2029
1.4.2 Global Naphazoline Hydrochloride Sales 2018-2029
1.4.3 Global Naphazoline Hydrochloride Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Naphazoline Hydrochloride Market Competition by Manufacturers
2.1 Global Naphazoline Hydrochloride Sales Market Share by Manufacturers (2018-2023)
2.2 Global Naphazoline Hydrochloride Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Naphazoline Hydrochloride Average Price by Manufacturers (2018-2023)
2.4 Global Naphazoline Hydrochloride Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Naphazoline Hydrochloride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Naphazoline Hydrochloride, Product Type & Application
2.7 Naphazoline Hydrochloride Market Competitive Situation and Trends
2.7.1 Naphazoline Hydrochloride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Naphazoline Hydrochloride Players Market Share by Revenue
2.7.3 Global Naphazoline Hydrochloride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Naphazoline Hydrochloride Retrospective Market Scenario by Region
3.1 Global Naphazoline Hydrochloride Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Naphazoline Hydrochloride Global Naphazoline Hydrochloride Sales by Region: 2018-2029
3.2.1 Global Naphazoline Hydrochloride Sales by Region: 2018-2023
3.2.2 Global Naphazoline Hydrochloride Sales by Region: 2024-2029
3.3 Global Naphazoline Hydrochloride Global Naphazoline Hydrochloride Revenue by Region: 2018-2029
3.3.1 Global Naphazoline Hydrochloride Revenue by Region: 2018-2023
3.3.2 Global Naphazoline Hydrochloride Revenue by Region: 2024-2029
3.4 North America Naphazoline Hydrochloride Market Facts & Figures by Country
3.4.1 North America Naphazoline Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Naphazoline Hydrochloride Sales by Country (2018-2029)
3.4.3 North America Naphazoline Hydrochloride Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Naphazoline Hydrochloride Market Facts & Figures by Country
3.5.1 Europe Naphazoline Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Naphazoline Hydrochloride Sales by Country (2018-2029)
3.5.3 Europe Naphazoline Hydrochloride Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Naphazoline Hydrochloride Market Facts & Figures by Country
3.6.1 Asia Pacific Naphazoline Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Naphazoline Hydrochloride Sales by Country (2018-2029)
3.6.3 Asia Pacific Naphazoline Hydrochloride Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Naphazoline Hydrochloride Market Facts & Figures by Country
3.7.1 Latin America Naphazoline Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Naphazoline Hydrochloride Sales by Country (2018-2029)
3.7.3 Latin America Naphazoline Hydrochloride Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Naphazoline Hydrochloride Market Facts & Figures by Country
3.8.1 Middle East and Africa Naphazoline Hydrochloride Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Naphazoline Hydrochloride Sales by Country (2018-2029)
3.8.3 Middle East and Africa Naphazoline Hydrochloride Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Naphazoline Hydrochloride Sales by Type (2018-2029)
4.1.1 Global Naphazoline Hydrochloride Sales by Type (2018-2023)
4.1.2 Global Naphazoline Hydrochloride Sales by Type (2024-2029)
4.1.3 Global Naphazoline Hydrochloride Sales Market Share by Type (2018-2029)
4.2 Global Naphazoline Hydrochloride Revenue by Type (2018-2029)
4.2.1 Global Naphazoline Hydrochloride Revenue by Type (2018-2023)
4.2.2 Global Naphazoline Hydrochloride Revenue by Type (2024-2029)
4.2.3 Global Naphazoline Hydrochloride Revenue Market Share by Type (2018-2029)
4.3 Global Naphazoline Hydrochloride Price by Type (2018-2029)
5 Segment by Application
5.1 Global Naphazoline Hydrochloride Sales by Application (2018-2029)
5.1.1 Global Naphazoline Hydrochloride Sales by Application (2018-2023)
5.1.2 Global Naphazoline Hydrochloride Sales by Application (2024-2029)
5.1.3 Global Naphazoline Hydrochloride Sales Market Share by Application (2018-2029)
5.2 Global Naphazoline Hydrochloride Revenue by Application (2018-2029)
5.2.1 Global Naphazoline Hydrochloride Revenue by Application (2018-2023)
5.2.2 Global Naphazoline Hydrochloride Revenue by Application (2024-2029)
5.2.3 Global Naphazoline Hydrochloride Revenue Market Share by Application (2018-2029)
5.3 Global Naphazoline Hydrochloride Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novartis AG
6.1.1 Novartis AG Corporation Information
6.1.2 Novartis AG Description and Business Overview
6.1.3 Novartis AG Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Novartis AG Naphazoline Hydrochloride Product Portfolio
6.1.5 Novartis AG Recent Developments/Updates
6.2 Allergan, Inc.
6.2.1 Allergan, Inc. Corporation Information
6.2.2 Allergan, Inc. Description and Business Overview
6.2.3 Allergan, Inc. Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Allergan, Inc. Naphazoline Hydrochloride Product Portfolio
6.2.5 Allergan, Inc. Recent Developments/Updates
6.3 Meda Pharmaceuticals Inc
6.3.1 Meda Pharmaceuticals Inc Corporation Information
6.3.2 Meda Pharmaceuticals Inc Description and Business Overview
6.3.3 Meda Pharmaceuticals Inc Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Meda Pharmaceuticals Inc Naphazoline Hydrochloride Product Portfolio
6.3.5 Meda Pharmaceuticals Inc Recent Developments/Updates
6.4 Bausch & Lomb Inc
6.4.1 Bausch & Lomb Inc Corporation Information
6.4.2 Bausch & Lomb Inc Description and Business Overview
6.4.3 Bausch & Lomb Inc Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bausch & Lomb Inc Naphazoline Hydrochloride Product Portfolio
6.4.5 Bausch & Lomb Inc Recent Developments/Updates
6.5 Cigna
6.5.1 Cigna Corporation Information
6.5.2 Cigna Description and Business Overview
6.5.3 Cigna Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Cigna Naphazoline Hydrochloride Product Portfolio
6.5.5 Cigna Recent Developments/Updates
6.6 Similasan Corporation
6.6.1 Similasan Corporation Corporation Information
6.6.2 Similasan Corporation Description and Business Overview
6.6.3 Similasan Corporation Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Similasan Corporation Naphazoline Hydrochloride Product Portfolio
6.6.5 Similasan Corporation Recent Developments/Updates
6.7 Visine
6.6.1 Visine Corporation Information
6.6.2 Visine Description and Business Overview
6.6.3 Visine Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Visine Naphazoline Hydrochloride Product Portfolio
6.7.5 Visine Recent Developments/Updates
6.8 Alcon
6.8.1 Alcon Corporation Information
6.8.2 Alcon Description and Business Overview
6.8.3 Alcon Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Alcon Naphazoline Hydrochloride Product Portfolio
6.8.5 Alcon Recent Developments/Updates
6.9 Viva Opti-Free
6.9.1 Viva Opti-Free Corporation Information
6.9.2 Viva Opti-Free Description and Business Overview
6.9.3 Viva Opti-Free Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Viva Opti-Free Naphazoline Hydrochloride Product Portfolio
6.9.5 Viva Opti-Free Recent Developments/Updates
6.10 Bausch & Lomb
6.10.1 Bausch & Lomb Corporation Information
6.10.2 Bausch & Lomb Description and Business Overview
6.10.3 Bausch & Lomb Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Bausch & Lomb Naphazoline Hydrochloride Product Portfolio
6.10.5 Bausch & Lomb Recent Developments/Updates
6.11 Systane
6.11.1 Systane Corporation Information
6.11.2 Systane Naphazoline Hydrochloride Description and Business Overview
6.11.3 Systane Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Systane Naphazoline Hydrochloride Product Portfolio
6.11.5 Systane Recent Developments/Updates
6.12 Rite Aid
6.12.1 Rite Aid Corporation Information
6.12.2 Rite Aid Naphazoline Hydrochloride Description and Business Overview
6.12.3 Rite Aid Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Rite Aid Naphazoline Hydrochloride Product Portfolio
6.12.5 Rite Aid Recent Developments/Updates
6.13 Walgreens
6.13.1 Walgreens Corporation Information
6.13.2 Walgreens Naphazoline Hydrochloride Description and Business Overview
6.13.3 Walgreens Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Walgreens Naphazoline Hydrochloride Product Portfolio
6.13.5 Walgreens Recent Developments/Updates
6.14 Staples
6.14.1 Staples Corporation Information
6.14.2 Staples Naphazoline Hydrochloride Description and Business Overview
6.14.3 Staples Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Staples Naphazoline Hydrochloride Product Portfolio
6.14.5 Staples Recent Developments/Updates
6.15 Clear eyes
6.15.1 Clear eyes Corporation Information
6.15.2 Clear eyes Naphazoline Hydrochloride Description and Business Overview
6.15.3 Clear eyes Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Clear eyes Naphazoline Hydrochloride Product Portfolio
6.15.5 Clear eyes Recent Developments/Updates
6.16 Refresh
6.16.1 Refresh Corporation Information
6.16.2 Refresh Naphazoline Hydrochloride Description and Business Overview
6.16.3 Refresh Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Refresh Naphazoline Hydrochloride Product Portfolio
6.16.5 Refresh Recent Developments/Updates
6.17 Murine
6.17.1 Murine Corporation Information
6.17.2 Murine Naphazoline Hydrochloride Description and Business Overview
6.17.3 Murine Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Murine Naphazoline Hydrochloride Product Portfolio
6.17.5 Murine Recent Developments/Updates
6.18 Tears naturale
6.18.1 Tears naturale Corporation Information
6.18.2 Tears naturale Naphazoline Hydrochloride Description and Business Overview
6.18.3 Tears naturale Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Tears naturale Naphazoline Hydrochloride Product Portfolio
6.18.5 Tears naturale Recent Developments/Updates
6.19 Genteal
6.19.1 Genteal Corporation Information
6.19.2 Genteal Naphazoline Hydrochloride Description and Business Overview
6.19.3 Genteal Naphazoline Hydrochloride Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Genteal Naphazoline Hydrochloride Product Portfolio
6.19.5 Genteal Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Naphazoline Hydrochloride Industry Chain Analysis
7.2 Naphazoline Hydrochloride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Naphazoline Hydrochloride Production Mode & Process
7.4 Naphazoline Hydrochloride Sales and Marketing
7.4.1 Naphazoline Hydrochloride Sales Channels
7.4.2 Naphazoline Hydrochloride Distributors
7.5 Naphazoline Hydrochloride Customers
8 Naphazoline Hydrochloride Market Dynamics
8.1 Naphazoline Hydrochloride Industry Trends
8.2 Naphazoline Hydrochloride Market Drivers
8.3 Naphazoline Hydrochloride Market Challenges
8.4 Naphazoline Hydrochloride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Novartis AG
Allergan, Inc.
Meda Pharmaceuticals Inc
Bausch & Lomb Inc
Cigna
Similasan Corporation
Visine
Alcon
Viva Opti-Free
Bausch & Lomb
Systane
Rite Aid
Walgreens
Staples
Clear eyes
Refresh
Murine
Tears naturale
Genteal

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂